Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citramel inhalation safety and tolerability study in healthy volunteers
ACTRN12615000634572Phase 2Completed
- Sponsor
- Breathe Easy
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Citramel in cystic fibrosis (CF), sponsored by Breathe Easy. Primary endpoints: Safety and Daily tolerability. Started Aug 2015; status: completed.
02
Drugs
Citramel
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12615000634572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000634572.